Increased monocyte to HDL cholesterol ratio in vitamin B12 deficiency: Is it related to cardiometabolic risk?
Abstract
Abstract. Vitamin B12 deficiency may have indirect cardiovascular effects in addition to hematological and neuropsychiatric symptoms. It was shown that the monocyte count-to-high density lipoprotein cholesterol (HDL-C) ratio (MHR) is a novel cardiovascular marker. In this study, the aim was to evaluate whether MHR was high in patients with vitamin B12 deficiency and its relationship with cardiometabolic risk factors. The study included 128 patients diagnosed with vitamin B12 deficiency and 93 healthy controls. Patients with vitamin B12 deficiency had significantly higher systolic blood pressure (SBP), diastolic blood pressure (DBP), MHR, C-reactive protein (CRP) and uric acid levels compared with the controls (median 139 vs 115 mmHg, p < 0.001; 80 vs 70 mmHg, p < 0.001; 14.2 vs 9.5, p < 0.001; 10.2 vs 4 mg/dl p < 0.001; 6.68 vs 4.8 mg/dl, p < 0.001 respectively). The prevalence of left ventricular hypertrophy was higher in vitamin B12 deficiency group (43.8%) than the control group (8.6%) (p < 0.001). In vitamin B12 deficiency group, a positive correlation was detected between MHR and SBP, CRP and uric acid (p < 0.001 r:0.34, p < 0.001 r:0.30, p < 0.001 r:0.5, respectively) and a significant negative correlation was detected between MHR and T-CHOL, LDL, HDL and B12 (p < 0.001 r: −0.39, p < 0.001 r: −0.34, p < 0.001 r: −0.57, p < 0.04 r: −0.17, respectively). MHR was high in vitamin B12 deficiency group, and correlated with the cardiometabolic risk factors in this group, which were SBP, CRP, uric acid and HDL. In conclusion, MRH, which can be easily calculated in clinical practice, can be a useful marker to assess cardiovascular risk in patients with vitamin B12 deficiency.
References
1 . Vitamin B12 deficiency: Recognition and management. Am Fam Physician. 2017;96(6):384–9.
2 . Vitamin B12 deficiency. BMJ. 2014;349:g5226.
3 . Clinical practice. Vitamin B12 deficiency. N Engl J Med. 2013;368(2):149–60.
4 . Vitamin B12 status in older adults living in Ontario long-term care homes: Prevalence and incidence of deficiency with supplementation as a protective factor. Appl Physiol Nutr Metab. 2016;41(2):219–22.
5 . Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014;166(4):496–513.
6 . An update on cobalamin deficiency in adults. QJM. 2009;102(1):17–28.
7 . The neuropsychiatry of vitamin B12 deficiency in elderly patients. J Neuropsychiatry Clin Neurosci. 2012;24(1):5–15.
8 . Effects of homocysteine on smooth muscle cell proliferation in both cell culture and artery perfusion culture models. J Surg Res. 2000;88(1):26–33.
9 . Is vitamin B12 deficiency a risk factor for cardiovascular disease in vegetarians? Am J Prev Med. 2015;48(6):e11–26.
10 . The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J Clin Invest. 1976;57(4):1079–82.
11 . Homocysteine level and coronary heart disease incidence: A systematic review and meta-analysis. Mayo Clin Proc. 2008;83(11):1203–12.
12 . Efficacy of folic acid supplementation in cardiovascular disease prevention: An updated meta-analysis of randomized controlled trials. Eur J Intern Med. 2012;23(8):745–54.
13 . Kardiyovasküler hastalıklarda trombosit fonksiyon testleri: patofizyolojiden klinik yaklaşıma. Cumhuriyet Med J. 2010;32(2):264–74.
14 . Vitamin B12 deficiency and hyperhomocysteinemia as correlates of cardiovascular risk factors in Indian subjects with coronary artery disease. J Cardiol. 2013;61(4):289–94.
15 . Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function. Curr Drug Metab. 2005;6(1):27–36.
16 Homocysteine upregulates resistin production from adipocytes in vivo and in vitro. Diabetes. 2008;57(4):817–27.
17 Vitamin B12 levels in Alzheimer’s disease: Association with clinical features and cytokine production. J Alzheimers Dis. 2010;19(2):481–8.
18 . A novel role for vitamin B(12): Cobalamins are intracellular antioxidants in vitro. Free Radic Biol Med. 2009;47(2):184–8.
19 . Vitamin B12 in relation to oxidative stress: A systematic review. Nutrients. 2019;11(2):482.
20
Expert panel on detection, evaluation and treatment of high blood cholesterol in adults . Executive summary of the third report of the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP III). JAMA. 2001;285(19):2486–97.21 Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459–72.
22 Association of monocyte-to-hdl cholesterol ratio with slow coronary flow is linked to systemic inflammation. Clin Appl Thromb Hemost. 2016;22(5):476–82.
23 Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. J Cell Physiol. 2018;233(12):9237–46.
24 . Protective effect of high density lipoprotein on endothelium-dependent vasodilatation. Int J Cardiol. 2000;73(3):231–6.
25 Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol. 2014;46(8):1619–25.
26 Is monocyte to HDL ratio superior to monocyte count in predicting the cardiovascular outcomes: Evidence from a large cohort of Chinese patients undergoing coronary angiography. Ann Med. 2016;48(5):305–12.
27 . Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: Old perspective with a new angle. Biochem Biophys Res Commun. 2011;408(1):1–5.
28 . 12 Vitamini Eksikliği Tanı ve Tedavi Klavuzu. Ulusal Tedavi Klavuzu. 2011.
29 . Hyperhomocysteinaemia and vitamin B12 deficiency: The long-term effects in cardiovascular disease. Cardiology. 2007;107(1):57–62.
30 Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: The EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol. 2007;49(5):547–53.
31 Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease. J Endocrinol Invest. 2014;37(3):261–8.
32 High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol. 2008;28(11):2071–7.
33 . CD16 + monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells. J Leukoc Biol. 2006;80(5):1156–64.
34 . High-density lipoprotein: A potent inhibitor of inflammation. Clin Exp Pharmacol Physiol. 2010;37(7):710–8.
35 . Antiinflammatory properties of HDL. Circ Res. 2004;95(8):764–72.
36 Relationship between monocyte/high-density lipoprotein cholesterol ratio and angiographic severity and extent of coronary artery disease. Koşuyolu Heart J. 2017;20(1):30–5.
37 Novel risk biomarker for infective endocarditis patients with normal left ventricular ejection fraction- monocyte to high-density lipoprotein cholesterol ratio. Circ J. 2017;82(1):283–8.
38 Monocyte to high-density lipoprotein ratio as a new prognostic marker in patients with STEMI undergoing primary percutaneous coronary intervention. Am J Emerg Med. 2016;34(2):240–4.
39 Monocyte to HDL cholesterol ratio predicts coronary artery disease severity and future major cardiovascular adverse events in acute coronary syndrome. Heart Lung Circ. 2016;25(11):1077–86.
40 Monocyte to HDL cholesterol ratio is associated with discharge and 3-month outcome in patients with acute intracerebral hemorrhage. J Neurol Sci. 2017;372:157–61.
41 . Elevated monocyte to high-density lipoprotein cholesterol ratio and endothelial dysfunction in Behçet disease. Angiology. 2018;69(1):65–70.
42 Monocyte/high-density lipoprotein ratio predicts the mortality in ischemic stroke patients. Neurol Neurochir Pol. 2018;52(2):150–5.
43 Relation between monocyte to high-density lipoprotein cholesterol ratio with presence and severity of isolated coronary artery ectasia. Am J Cardiol. 2015;116(11):1685–9.
44 . How I investigate monocytosis. Int J Lab Hematol. 2018;40(2):107–14.
45 . Inheritance of high and low HDL: Mechanisms and management. Curr Opin Lipidol. 2019;30(4):307–13.
46 . A new inflammatory marker: Elevated monocyte to HDL cholesterol ratio associated with smoking. J Clin Med. 2018;7(4):76.
47 . Potential anti-inflammatory effects of proton pump inhibitors: A review and discussion of the clinical implications. Dig Dis Sci. 2009;54(11):2312–7.
48 Alterations of plasma high-density lipoprotein cholesterol levels associated with consumption of selected medications: The Lipid Research Clinics Program Prevalence Study. Circulation. 1980;62 (4 Pt 2): IV77–82.
